Pevonedistat, a first-in-class NEDD8-activating enzyme (NAE) inhibitor, combined with azacitidine, in patients with AML.
about
Pevonedistat, a first-in-class NEDD8-activating enzyme (NAE) inhibitor, combined with azacitidine, in patients with AML.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Pevonedistat, a first-in-class ...... itidine, in patients with AML.
@en
Pevonedistat, a first-in-class ...... itidine, in patients with AML.
@nl
type
label
Pevonedistat, a first-in-class ...... itidine, in patients with AML.
@en
Pevonedistat, a first-in-class ...... itidine, in patients with AML.
@nl
prefLabel
Pevonedistat, a first-in-class ...... itidine, in patients with AML.
@en
Pevonedistat, a first-in-class ...... itidine, in patients with AML.
@nl
P2093
P2860
P50
P1433
P1476
Pevonedistat, a first-in-class ...... acitidine in patients with AML
@en
P2093
Harry P Erba
Hélène M Faessel
James M Foran
Jesus G Berdeja
Michael B Maris
Saran Vardhanabhuti
Steven Coutre
P2860
P304
P356
10.1182/BLOOD-2017-09-805895
P407
P50
P577
2018-01-18T00:00:00Z